AARD compared with NUVB: revenue, margins and what each company keeps, and the suppliers and customers both name

AARDAardvark Therapeutics, Inc.

Mkt capRevenueRevenue

NUVBNuvation Bio Inc.

Mkt capRevenueRevenue

Compare

AARDAardvark Therapeutics, Inc.

NUVBNuvation Bio Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AARD

0 of 3at or beyond implied

Reportimpliedrealized× implied

Aug 12 '26±54.2%▼−8.62%×0.16

May 7 '26±56.7%▼−4.92%×0.09

Mar 24 '26±89.9%▼−7.26%×0.08

Nov 14 '25—▼−8.66%—

NUVB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±17.5%▼−11.42%×0.65

Aug 6 '26±19.6%▼−4.08%×0.21

= impliedAARD realized, solidNUVB realized, hatchedOne scale, both sides: full bar = 90%× = |realized| ÷ impliedSource: market data

May 5 '26

±14.9%

▲+9.52%

×0.64

Mar 3 '26±23.9%▼−25.34%×1.06

AARDAardvark Therapeutics, Inc.

1.16▲+4.21%· post 1.13

Mkt cap$25.6MRevenue—Revenue—

NUVBNuvation Bio Inc.

4.17▼−0.48%· post 4.17

ClosedNov 6 '26

Mkt cap$1.5BRevenue$45MQ3 FY26Revenue$63MFY25

Compare

ClosedNov 6 '26

AARDAardvark Therapeutics, Inc.

NUVBNuvation Bio Inc.

1.16▲+4.21%post 1.13

Price

4.17▼−0.48%post 4.17

$25.6M

Mkt cap

$1.5B

—

Revenue

$45MQ3 FY26

—

Revenue

$63MFY25

AARD1.16▲+4.21%vsNUVB4.17▼−0.48%ClosedNov 6 '26